Literature DB >> 22470250

The five ps of acute ischemic stroke treatment: parenchyma, pipes, perfusion, penumbra, and prevention of complications.

Robert A Felberg, Andrew Naidech.   

Abstract

Stroke is a treatable disease. Despite the therapeutic nihilism of the past, the advent of thrombolysis has changed the way stroke treatment is approached. Acute ischemic stroke is a challenging and heterogeneous disease, and treatment must be based on an understanding of the underlying pathophysiology of ischemia. Interventions are designed to improve neuronal salvage and outcome. The underlying tenets of stroke therapy focus on the brain parenchyma, arterial flow (pipes), perfusion, the ischemic milieu or penumbra, and prevention of complications. This article focuses on the practical issues of ischemic stroke care with a brief review of supporting literature.

Entities:  

Year:  2003        PMID: 22470250      PMCID: PMC3314416     

Source DB:  PubMed          Journal:  Ochsner J        ISSN: 1524-5012


  40 in total

1.  Clinical trial of an air-circulating cooling blanket for fever control in critically ill neurologic patients.

Authors:  S Mayer; C Commichau; N Scarmeas; M Presciutti; J Bates; D Copeland
Journal:  Neurology       Date:  2001-02-13       Impact factor: 9.910

2.  Effects of poststroke pyrexia on stroke outcome : a meta-analysis of studies in patients.

Authors:  C Hajat; S Hajat; P Sharma
Journal:  Stroke       Date:  2000-02       Impact factor: 7.914

3.  Balloon angioplasty of intracranial arteries for stroke prevention.

Authors:  A S Callahan; B L Berger
Journal:  J Neuroimaging       Date:  1997-10       Impact factor: 2.486

4.  Acute blood glucose level and outcome from ischemic stroke. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators.

Authors:  A Bruno; J Biller; H P Adams; W R Clarke; R F Woolson; L S Williams; M D Hansen
Journal:  Neurology       Date:  1999-01-15       Impact factor: 9.910

5.  PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism.

Authors:  G J del Zoppo; R T Higashida; A J Furlan; M S Pessin; H A Rowley; M Gent
Journal:  Stroke       Date:  1998-01       Impact factor: 7.914

6.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

7.  A pilot study of hyperbaric oxygen in the treatment of human stroke.

Authors:  D C Anderson; A G Bottini; W M Jagiella; B Westphal; S Ford; G L Rockswold; R B Loewenson
Journal:  Stroke       Date:  1991-09       Impact factor: 7.914

8.  Clomethiazole acute stroke study (CLASS): results of a randomized, controlled trial of clomethiazole versus placebo in 1360 acute stroke patients.

Authors:  N G Wahlgren; K W Ranasinha; T Rosolacci; C L Franke; P M van Erven; T Ashwood; L Claesson
Journal:  Stroke       Date:  1999-01       Impact factor: 7.914

Review 9.  How do stroke units improve patient outcomes? A collaborative systematic review of the randomized trials. Stroke Unit Trialists Collaboration.

Authors: 
Journal:  Stroke       Date:  1997-11       Impact factor: 7.914

10.  Fever in acute stroke worsens prognosis. A prospective study.

Authors:  G Azzimondi; L Bassein; F Nonino; L Fiorani; L Vignatelli; G Re; R D'Alessandro
Journal:  Stroke       Date:  1995-11       Impact factor: 7.914

View more
  2 in total

1.  Recent publications by ochsner authors.

Authors: 
Journal:  Ochsner J       Date:  2003

2.  Paradigm Shift in Stroke Prevention: Need of the Hour.

Authors:  Pushpendra Nath Renjen
Journal:  Ann Indian Acad Neurol       Date:  2017 Apr-Jun       Impact factor: 1.383

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.